GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, sales was NGN 20,425.58 million compared to NGN 16,452.58 million a year ago. Net income was NGN 483.54 million compared to NGN 122.7 million a year ago. Basic earnings per share from continuing operations was NGN 0.4 compared to NGN 0.1 a year ago. Diluted earnings per share from continuing operations was NGN 0.4 compared to NGN 0.1 a year ago.